Parallax Health Sciences Inc (PRLX) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
1327 OCEAN AVENUE, SUITE M SANTA MONICA, CA 90401 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 6 | 0 | 3 | 63 | ||
| Cash and cash equivalents | 6 | 0 | 3 | 63 | ||
| Receivables | 44 | 838 | ||||
| Inventory, net of allowances, customer advances and progress billings | 410 | |||||
| Inventory | 410 | |||||
| Other undisclosed current assets | 52 | 9 | 104 | |||
| Total current assets: | 59 | 0 | 55 | 1,415 | ||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 2 | 10 | 39 | |||
| Long-term investments and receivables | 170 | 170 | ||||
| Accounts and financing receivable, after allowance for credit loss | 170 | 170 | ||||
| Intangible assets, net (including goodwill) | 1,243 | 1,364 | 3,083 | 977 | ||
| Goodwill | 785 | 785 | 785 | 785 | ||
| Intangible assets, net (excluding goodwill) | 458 | 579 | 2,298 | 192 | ||
| Deposits noncurrent assets | 23 | |||||
| Other undisclosed noncurrent assets | 56 | 22 | ||||
| Total noncurrent assets: | 1,301 | 1,364 | 3,285 | 1,209 | ||
| TOTAL ASSETS: | 1,360 | 1,364 | 3,340 | 2,624 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 2,083 | 2,655 | 6,027 | 3,974 | ||
| Accounts payable | 1,128 | 831 | 2,021 | 1,458 | ||
| Accrued liabilities | 250 | 1,000 | ||||
| Employee-related liabilities | 339 | 402 | 368 | 45 | ||
| Taxes payable | 38 | 35 | ||||
| Interest and dividends payable | 376 | 450 | 1,724 | 804 | ||
| Other undisclosed accounts payable and accrued liabilities | 240 | 722 | 876 | 1,632 | ||
| Debt | 2,587 | 1,317 | 741 | |||
| Derivative instruments and hedges, liabilities | 63 | 24 | ||||
| Due to related parties | 1,235 | 1,005 | 1,284 | 425 | ||
| Other undisclosed current liabilities | 1,755 | 115 | 13 | 11 | ||
| Total current liabilities: | 7,723 | 5,116 | 8,065 | 4,410 | ||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 760 | 934 | 18,464 | 13,690 | ||
| Long-term debt, excluding current maturities | 760 | 934 | 18,464 | 13,690 | ||
| Liabilities, other than long-term debt | 633 | 525 | 1,167 | 1,357 | ||
| Due to related parties | 633 | 491 | 1,167 | 1,357 | ||
| Derivative instruments and hedges, liabilities | 34 | |||||
| Other undisclosed noncurrent liabilities | 2,498 | 740 | 3,034 | 740 | ||
| Total noncurrent liabilities: | 3,892 | 2,199 | 22,665 | 15,788 | ||
| Total liabilities: | 11,614 | 7,315 | 30,730 | 20,198 | ||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | (10,255) | (5,950) | 6,546 | 17,684 | ||
| Preferred stock | 1 | 1 | 1 | 1 | ||
| Common stock | 250 | 158 | 137 | 107 | ||
| Common stock, value, subscriptions | (2) | |||||
| Additional paid in capital | 21,552 | 13,081 | 6,246 | 2,216 | ||
| Deferred compensation equity | (1,149) | (1,810) | ||||
| Accumulated deficit | (32,057) | (19,191) | ||||
| Warrants and rights outstanding | 1,972 | 15,362 | ||||
| Stockholders' equity note, subscriptions receivable | (1) | (2) | ||||
| Other undisclosed stockholders' equity attributable to parent | 1,149 | |||||
| Other undisclosed stockholders' equity | (33,935) | (35,258) | ||||
| Total stockholders' equity: | (10,255) | (5,950) | (27,390) | (17,574) | ||
| TOTAL LIABILITIES AND EQUITY: | 1,360 | 1,364 | 3,340 | 2,624 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|
| Revenues | 129 | 12 | 3,195 | 22,749 | |
| Revenue, net | ✕ | ✕ | 3,195 | 22,749 | |
| Cost of revenue (Cost of Goods and Services Sold) | (17) | (20) | (3,226) | (19,188) | |
| Gross profit: | 112 | (9) | (31) | 3,561 | |
| Operating expenses | (6,505) | (6,626) | (7,087) | (6,708) | |
| Operating loss: | (6,394) | (6,635) | (7,118) | (3,147) | |
| Nonoperating income (expense) | (6,473) | 22,243 | (6,758) | (10,035) | |
| Interest and debt expense | (927) | 22,858 | 918 | ||
| Income (loss) from continuing operations before income taxes: | (13,794) | 38,466 | (13,877) | (12,264) | |
| Income tax expense | (3) | (21) | |||
| Other undisclosed income (loss) from continuing operations | 927 | (22,858) | |||
| Income (loss) from continuing operations: | (12,866) | 15,608 | (13,879) | (12,285) | |
| Income (loss) from discontinued operations | (824) | 954 | |||
| Income (loss) before gain (loss) on sale of properties: | (12,866) | 14,784 | (12,925) | (12,285) | |
| Other undisclosed net income (loss) | 824 | (951) | (897) | ||
| Net income (loss): | (12,866) | 15,608 | (13,877) | (13,182) | |
| Other undisclosed net loss attributable to parent | (824) | ||||
| Net income (loss) available to common stockholders, diluted: | (12,866) | 14,784 | (13,877) | (13,182) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|
| Net income (loss): | (12,866) | 15,608 | (13,877) | (13,182) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (12,866) | 15,608 | (13,877) | (13,182) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.